Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Int J Geriatr Psychiatry. 2021 Jul;36(7):1050-1058. doi: 10.1002/gps.5530. Epub 2021 Mar 15.
Neuropsychiatric symptoms (NPS) are often present in individuals with mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia. NPS are associated with structural and functional changes in the brain such as atrophy, regional hypometabolism, and hypoperfusion, considered proxies of neurodegeneration. Our objective was to evaluate the association between NPS and regional cerebral tau burden, a more direct representation of neurodegeneration, in cognitively normal (CN), MCI, and AD dementia individuals.
Cross-sectional NPS were assessed using the Neuropsychiatric Inventory (NPI) in 410 CN, 199 MCI, and 61 AD dementia participants who underwent flortaucipir tau positron emission tomography as part of the AD Neuroimaging Initiative (ADNI). Total NPI score and two factors of NPS (affective and hyperactive) were used in analyses. Linear regression models with backward elimination were employed with NPI as dependent variable and regional tau or tau-amyloid interaction as predictor of interest. Covariates included education, age, sex, Rey Auditory Verbal Learning Test Total Learning, and Trail Making Test B.
There were significant associations (p < 0.05) between the NPI variables (total score, Affective factor) and entorhinal and precuneus tau across all participants. These associations were also significant for the tau-amyloid interaction. These effects were significant in cognitively symptomatic participants (MCI and AD dementia), but not in CN participants.
Increased tau burden in the entorhinal and precuneus cortices was modestly associated with greater NPS in MCI and AD dementia. Further evaluation of NPS and their effect on early-stage AD could aid in finding new interventions and slowing disease progression.
神经精神症状(NPS)在轻度认知障碍(MCI)和阿尔茨海默病(AD)痴呆患者中经常出现。NPS 与大脑结构和功能变化有关,如萎缩、区域性低代谢和低灌注,被认为是神经退行性变的替代物。我们的目的是评估 NPS 与认知正常(CN)、MCI 和 AD 痴呆个体中区域脑 tau 负担之间的关系,tau 负担是神经退行性变的更直接表现。
在作为 AD 神经影像学倡议(ADNI)一部分接受 flortaucipir tau 正电子发射断层扫描的 410 名 CN、199 名 MCI 和 61 名 AD 痴呆参与者中,使用神经精神病学问卷(NPI)评估横断面 NPS。总 NPI 评分和 NPS 的两个因子(情感和多动)用于分析。采用带有向后消除的线性回归模型,以 NPI 为因变量,以感兴趣的区域 tau 或 tau-淀粉样蛋白相互作用为预测变量。协变量包括教育、年龄、性别、 Rey 听觉言语学习测试总学习和 Trail Making 测试 B。
在所有参与者中,NPI 变量(总分、情感因子)与内嗅皮质和楔前叶 tau 之间存在显著关联(p<0.05)。tau-淀粉样蛋白相互作用也存在显著关联。这些效应在认知症状性参与者(MCI 和 AD 痴呆)中显著,但在 CN 参与者中不显著。
内嗅皮质和楔前叶皮质 tau 负担增加与 MCI 和 AD 痴呆患者的 NPS 增加适度相关。进一步评估 NPS 及其对早期 AD 的影响可能有助于找到新的干预措施并减缓疾病进展。